Clinlab Navigator

Neurofilament Light Chain

Neurofilament light chain (NfL) is a neuronal scaffolding protein that is exclusively expressed in the large caliber axons of neurons. During axonal damage, NfL is released into CSF and subsequently into blood. Concentration is 40 times higher in CSF than in blood. NfL concentration in blood is proportional to the degree of axonal damage in a variety of neurological disorders, including traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, frontotemporal dementia, Alzheimer disease, and other neurodegenerative diseases.

Plasma NfL concentrations increase with age in healthy individuals.  NfL levels in the blood of healthy controls increase by 2.2% per year between the ages of 18 years and 70 years. Reference values are age dependent.

NfL levels may be elevated in patients with stroke chronic kidney disease, atrial fibrillation, and myocardial infarction.


Gaetani L et al. Neurofilament light chain as a biomarker in neurological disorders,
J Neurol Neurosurg Psychiatry, 2019 Aug;90(8):870-881.

Thebault S et al. Blood neurofilament light chain: The neurologist’s troponin? Biomedicines 2020;8:523

Updated Articles

C1 Esterase Inhibitor

Hereditary angioedema is caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH). C1 esterase inhibitor is a serum alpha-2 globulin and a member of the serpin family of protease inhibitors that is primarily synthesized by the liver.…

New Articles

Babesia microti

Babesiosis is a tickborne zoonotic disease that is caused primarily by the intraerythrocytic parasite Babesia in the United States. The first case of human babesiosis acquired in the United States was identified in 1969 on Nantucket Island,…


Quantity of…

SARS-CoV-2, the causative agent of COVID-19, spreads through exhaled breath during breathing, coughing, talking, and singing. Olfactory scientists at Northwestern University Feinberg School of Medicine developed a portable device for the collection…